Evidence supporting the use of: Aniracetam
For the body system: Acetylcholine
Synopsis
Source of validity: Scientific
Rating (out of 5): 2
Aniracetam is a synthetic nootropic compound belonging to the racetam family, which is known to modulate cholinergic neurotransmission. Its use to support the acetylcholine system is primarily based on preclinical and limited clinical studies. Research suggests that aniracetam can enhance acetylcholine release and increase the density or sensitivity of acetylcholine receptors in the brain. Animal studies have shown improvements in memory and learning, believed to be mediated through these cholinergic mechanisms. Some human studies have indicated potential cognitive benefits in elderly populations with cognitive decline, though results are not robust or consistent across larger, well-controlled trials. The evidence for aniracetam specifically supporting the acetylcholine system is stronger than for many other nootropics, but still falls short of definitive clinical validation. Regulatory agencies have not approved aniracetam for medical use in most countries, and it remains an unlicensed compound in the United States. Overall, while there is a mechanistic rationale and some supporting evidence, the quality and quantity of human research are limited, justifying a moderate evidence rating.
Other ingredients that support Acetylcholine
acetyl l-carnitinewaterhyssop
choline
citicoline
ginkgo biloba
glycerophosphocholine (GPC)
huperzine A
lecithin
lion's mane
magnesium
phosphatidylcholine
phosphatidylserine
polygala root
rosemary
sage
vinpocetine
terpene lactones
Alpha glyceryl
Areca
Aniracetam
Bilobalide
Baccosides
Bacopin
Brahmi
Bacopa
bacoside
Centrophenoxine
Cytisine
Convolvulus prostratus
Convolvulus Pluricaulis
Celastrus
Deanol
Egg